Implementations by Phenotype

Title Phenotypesort ascending Institution Algorithm Type Total Cases Total Controls PPV Sensitivity
Network Combined Dataset - Diverticulosis Diverticulosis and Diverticulitis Case, Control 6,173 4,969
Diverticulosis Implementation - Columbia Diverticulosis and Diverticulitis Columbia University Case, Control 66 689
Geisinger eMERGE3 Combined Implementation Diverticulosis and Diverticulitis Geisinger Case, Control 97%, 94%
Harvard Implementation Diverticulosis and Diverticulitis Harvard Medical School Case, Control 884 770
VU E3 implementation Diverticulosis and Diverticulitis Vanderbilt University Medical Center Case, Control
Mayo Clinic eMERGE III Implementation Diverticulosis and Diverticulitis Mayo Clinic Case, Control 3,679 2,459
GHUW Diverticulitis Diverticulosis and Diverticulitis GHRI/UW Case, Control
NU e3 Diverticulosis Diverticulosis and Diverticulitis Northwestern University Case, Control 1,273 1,211
Validation of ACEi-induced cough algorithm ACE Inhibitor (ACE-I) induced cough Mayo Clinic Case, Control 100%, 96%
NU ACE Inhibitor (ACE-I) induced cough implementation ACE Inhibitor (ACE-I) induced cough Northwestern University The Feinberg School of Medicine Case, Control 100%, 98%
Marshfield ACE-I cough implentation ACE Inhibitor (ACE-I) induced cough Marshfield Clinic Research Foundation Case, Control 25 25 100%, 96%
Network Combined Dataset - ACE-I induced Cough ACE Inhibitor (ACE-I) induced cough Case, Control
ACEi Cough Implementation - Columbia ACE Inhibitor (ACE-I) induced cough Columbia University Case, Control 17 233
VUMC ACEi cough implementation ACE Inhibitor (ACE-I) induced cough Vanderbilt University Case, Control 100%, 100% 96%
Clopidogrel Poor Metabolizers-Columbia Clopidogrel Poor Metabolizers Columbia University Case Only
Demonstration Project AF Implementation Atrial Fibrillation - Demonstration Project Vanderbilt University Case, Control 98%, 100%
Demonstration Project Crohn's Disease Implementation Crohn's Disease - Demonstration Project Vanderbilt University Case, Control 100%, 100%
Demonstration Project MS Implementation Multiple Sclerosis - Demonstration Project Vanderbilt University Case, Control 87%, 100%
Demonstration Project RA Implementation Rheumatoid Arthritis - Demonstration Project Vanderbilt University Case, Control 97%, 100%
Demonstration Project T2D Implementation Type 2 Diabetes - Demonstration Project Vanderbilt University Case, Control 100%, 100%
Vanderbilt implementation Clostridium Difficile Colitis Case, Control 100%, 100%
Marshfield C-diff implementation Clostridium Difficile Colitis Marshfield Clinic Research Foundation Case, Control 21 10 100%, 100%
CDiff Implementation - Columbia Clostridium Difficile Colitis Columbia University Case, Control 107 139
Geisinger c.Diff eMERGE3 Implementation Clostridium Difficile Colitis Geisinger Case, Control 20 20 100%, 100% 100%, 100%
VU E3 implementation Clostridium Difficile Colitis Vanderbilt University Medical Center Case, Control

Pages